Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX)

Historical Holders from Q4 2023 to Q3 2025

Symbol
PRAX on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
20.9M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
24.7M
Holdings value
$1.31B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
149
Number of buys
85
Number of sells
-64
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 12.3% -0.83% $146M $12.2M 2.76M +9.1% JANUS HENDERSON GROUP PLC 30 Sep 2025
Point72 Asset Management, L.P. 9.6% +32.9% $110M $28.7M 2.07M +35.4% Steven A. Cohen 30 Sep 2025
PERCEPTIVE ADVISORS LLC 6.69% +37.8% $57.3M $16M 1.36M +38.9% Perceptive Advisors LLC 15 Jul 2025
Adage Capital Management, L.P. 5.29% -54.5% $69.2M -$56.7M 1.31M -45% Adage Capital Management, L.P. 31 Oct 2025
Venrock Healthcare Capital Partners III, L.P. 4.9% -20% $37.8M -$6.47M 1.02M -14.6% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2025
PRICE T ROWE ASSOCIATES INC /MD/ 4.8% $53.2M 1M T. Rowe Price Associates, Inc. 30 Sep 2025
Cormorant Asset Management, LP 4% -46.5% $53M -$33.1M 1M -38.5% Cormorant Asset Management, LP 30 Sep 2025
Soleus Capital Master Fund, L.P. 4.6% -8% $40.7M -$2.14M 967K -5.01% Soleus Capital Master Fund, L.P. 30 Jun 2025
Capital Research Global Investors 4.2% $31.8M 854K Capital Research Global Investors 31 Mar 2025
MORGAN STANLEY 2.9% -55% $32.8M -$28.6M 618K -46.6% Morgan Stanley 30 Sep 2025

Institutional Holders of Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 24.7M $1.31B +$38.9M $53.00 149
2025 Q2 24.2M $1.02B +$43.5M $42.05 141
2025 Q1 23.4M $886M +$1.34M $37.87 147
2024 Q4 21.7M $1.67B +$224M $76.96 160
2024 Q3 18.9M $1.09B +$44M $57.54 132
2024 Q2 18.4M $762M +$67.5M $41.36 113
2024 Q1 15.9M $971M +$515M $61.02 110
2023 Q4 7.56M $168M +$168M $22.28 57